Zacks Investment Research on MSN
Can Merck's new drugs & pipeline ease Keytruda LOE concerns?
Merck MRK is focusing on driving long-term growth through the newer products and a promising set of pipelines as its ...
Study could lead to an effective new option to reduce the risk of heart attacks and strokes for millions who cannot control ...
A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of ...
Merck & Co. Inc. (NYSE:MRK) ranks among the 14 safe stocks to buy now for a starter stock portfolio. Merck & Co. Inc. (NYSE:MRK) ranks among the 14 safe stocks to buy now for a starter stock portfolio ...
In a potential leap forward in the global fight against the pandemic, drugmaker Merck said Friday that its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths by half.
Merck's animal health unit got approval for a drug to treat and control certain ticks in dogs from the Food and Drug Administration. Merck said Wednesday its Bravecto Quantum is now approved to treat ...
Johnson & Johnson JNJ and Merck MRK are among the top U.S. healthcare giants, making them ideal candidates for a direct ...
WASHINGTON (AP) — A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins, researchers reported Wednesday. It’s still ...
Merck said on Monday it would split its business into two, creating a division for its cancer franchise while grouping its non-oncology treatments separately.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new clinical data from the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results